Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference

About this update from Edwards Lifesciences Corporation

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":392,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/221ffa83dd22ff2f3a1585c6ee8c204e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oW.323dEWUkbP0vSINcyvg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTg2MztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/221ffa83dd22ff2f3a1585c6ee8c204e","width":392,"height":480}},"lazy":false},{"type":"text","content":"IRVINE, Calif., December 18, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026.","length":198,"tagName":"p"},{"type":"text","content":"Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.","length":355,"tagName":"p"},{"type":"text","content":"About Edwards Lifesciences","length":26,"tagName":"p"},{"type":"text","content":"Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.","length":460,"tagName":"p"},{"type":"text","content":"Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.","length":172,"tagName":"p"},{"type":"text","content":"View source version on businesswire.com: https://www.businesswire.com/news/home/20251218869141/en/","length":98,"tagName":"p"},{"type":"text","content":"Contacts","length":8,"tagName":"p"},{"type":"text","content":"Media Contact: Amy Meshulam, [email protected] Investor Contact: Mark Wilterding, [email protected]","length":113,"tagName":"p"}]

More updates from Edwards Lifesciences Corporation